DK1007052T3 - Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse - Google Patents
Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelseInfo
- Publication number
- DK1007052T3 DK1007052T3 DK98942166T DK98942166T DK1007052T3 DK 1007052 T3 DK1007052 T3 DK 1007052T3 DK 98942166 T DK98942166 T DK 98942166T DK 98942166 T DK98942166 T DK 98942166T DK 1007052 T3 DK1007052 T3 DK 1007052T3
- Authority
- DK
- Denmark
- Prior art keywords
- progesterones
- oral contraception
- endometrically
- atrophizing
- sparing
- Prior art date
Links
- 239000000262 estrogen Substances 0.000 title abstract 3
- 229940011871 estrogen Drugs 0.000 title abstract 3
- 239000000186 progesterone Substances 0.000 title 2
- 150000003146 progesterones Chemical class 0.000 title 2
- 230000002357 endometrial effect Effects 0.000 title 1
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5710997P | 1997-08-27 | 1997-08-27 | |
| PCT/US1998/017288 WO1999009993A1 (fr) | 1997-08-27 | 1998-08-20 | Associations de progestatifs conservant l'endometre et de progestatifs atrophiant l'endometre avec des oestrogenes, destinees a la contraception orale |
| EP98942166A EP1007052B1 (fr) | 1997-08-27 | 1998-08-20 | Associations de progestatifs conservant l'endometre et de progestatifs atrophiant l'endometre avec des oestrogenes, destinees a la contraception orale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007052T3 true DK1007052T3 (da) | 2005-01-31 |
Family
ID=22008560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98942166T DK1007052T3 (da) | 1997-08-27 | 1998-08-20 | Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1007052B1 (fr) |
| JP (1) | JP2001513566A (fr) |
| AT (1) | ATE279198T1 (fr) |
| AU (1) | AU9028098A (fr) |
| DE (1) | DE69827017T2 (fr) |
| DK (1) | DK1007052T3 (fr) |
| ES (1) | ES2230711T3 (fr) |
| PT (1) | PT1007052E (fr) |
| WO (1) | WO1999009993A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| US7855190B2 (en) * | 2003-07-16 | 2010-12-21 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| BRPI0414945A (pt) * | 2003-10-01 | 2006-11-07 | Janssen Pharmaceutica Nv | regimes contraceptivos trifásicos estendidos |
| EP1535618A1 (fr) | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Préparation pharmaceutique pour le traitement hormonal continuel sur plus de 21-28 jours comprenant deux compositions d'estrogène et/ou de progestine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| US4616006A (en) * | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| DK174724B1 (da) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
| HU214598B (hu) * | 1987-09-24 | 1998-04-28 | Jencap Research Ltd | Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására |
| DE4104385C1 (fr) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1998
- 1998-08-20 DK DK98942166T patent/DK1007052T3/da active
- 1998-08-20 DE DE69827017T patent/DE69827017T2/de not_active Expired - Lifetime
- 1998-08-20 ES ES98942166T patent/ES2230711T3/es not_active Expired - Lifetime
- 1998-08-20 AT AT98942166T patent/ATE279198T1/de active
- 1998-08-20 JP JP2000507383A patent/JP2001513566A/ja not_active Ceased
- 1998-08-20 AU AU90280/98A patent/AU9028098A/en not_active Abandoned
- 1998-08-20 PT PT98942166T patent/PT1007052E/pt unknown
- 1998-08-20 EP EP98942166A patent/EP1007052B1/fr not_active Expired - Lifetime
- 1998-08-20 WO PCT/US1998/017288 patent/WO1999009993A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1007052B1 (fr) | 2004-10-13 |
| EP1007052A1 (fr) | 2000-06-14 |
| DE69827017T2 (de) | 2006-03-09 |
| ATE279198T1 (de) | 2004-10-15 |
| AU9028098A (en) | 1999-03-16 |
| WO1999009993A1 (fr) | 1999-03-04 |
| PT1007052E (pt) | 2005-01-31 |
| JP2001513566A (ja) | 2001-09-04 |
| ES2230711T3 (es) | 2005-05-01 |
| DE69827017D1 (de) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970704430A (ko) | 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity) | |
| CY2009015I1 (el) | Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο | |
| ES2132645T3 (es) | Uso en una composicion farmaceutica. | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| MX9203278A (es) | Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina. | |
| FI20115742L (fi) | Mometasonifuroaatin käyttö lääkkeen valmistuksessa | |
| LU91429I2 (fr) | "Furoate de fluticasone et ses solvates(AVAMYS)" | |
| ID22565A (id) | Penggunaan nanodispersi dalam formulasi akhir obat | |
| FI972642L (fi) | Galeeninen yksikkökoostumus käytettäväksi paikallisesti hedelmöityksen ehkäisyyn ja/tai sukupuoliteitse välittyvien sairauksien ja/tai HIV:n vastaiseen taisteluun | |
| ES2097748T3 (es) | Uso de derivados funcionales de la molecula de adhesion intercelular icam-1 en la terapia antivirica. | |
| NO20004419L (no) | Ny anvendelse | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| TR199801511T2 (xx) | Farmas�tik bile�im. | |
| NO308581B1 (no) | Anvendelse av et antiprogestin og et progestin ved fremstilling av et medikament, implantat samt prevensjonssett inneholdende disse | |
| NO20025157L (no) | Kreftterapi | |
| NO995657L (no) | Kombinasjonsterapi for endring av human seksuell respons | |
| DK1007052T3 (da) | Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse | |
| AR030140A1 (es) | Composiciones derivadas de la 2-piridinamina y metodos relacionados | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| AU1518902A (en) | Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies | |
| CA2151476A1 (fr) | Utilisation d'inhibiteurs de la cyclo-oxygenase dans la fabrication d'un medicament ameliorant l'irrigation sanguine de l'uterus | |
| CY1108053T1 (el) | Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου |